RxDoctor Payments Data

Thomas Ross

Family Medicine · Des Moines, IANPI 1114997731

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $165,711 of the $169,928 with a category attached, or 97.5%. Organon accounts for 82.0% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2022 at $60,798 and has fallen 76.8% since, to $14,102 in 2025. Among family medicine clinicians in IA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$169,928in general payments, 2019–2025

Across 203 payments — averaging $837.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Organon$139K
  • Merck$30K
  • AstraZeneca$39

What the payments were for

  • Speaking & faculty fees$165,71198%
  • Travel & lodging$3,8732%
  • Food & beverage$3450%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Organon145$139,394
Merck57$30,495
AstraZeneca1$39

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$169,928 in reported general payments places this provider in the 95th percentile of 1,357 family medicine providers in Iowa.

See all family medicine providers in Iowa →

Other family medicine in Des Moines

See the full list for Iowa →

Where these figures come from

Is this you, or does something look wrong? →